The expression of DNMT1 in pathologic scar fibroblasts and the effect of 5-aza-2-deoxycytidine on cytokines of pathologic scar fibroblasts

Wounds

Volumn 26, Issue 5, 2014, Pages 139-146

  Yang, E ^a   Zou, Qipa ^a   Zhang, Hengshu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

5 aza 2 deoxycytidine; DNA methylationtransferase; Mrna; Pathological scars; Smad7; TGF 1

Indexed keywords

EID: 84900391550     PISSN: 10447946     EISSN: 19432704     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sen GL, Reuter JA, Webster DE, Zhu L, Khavari PA. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature. 2010;463(7280):563-567.
2. Egger G, Jeong S, Escobar SG, et al. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc Natl Acad Sci USA. 2006;103(38):14080-14085
3. Gordon KJ, Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta. 2008;1782(4):197-228.
4. Liu W, Wang DR, Cao YL. TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther. 2004;4(1):123-136.
5. Chen W, Fu X, Sheng Z. Review of current progress in the structure and function of Smad proteins. Chin Med J (Engl). 2002;115(3):446-450.
6. Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dematol Sci. 2004;35(2):83-92.
7. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 2006;18(4):396-402.
8. Russell SB, Russell JD, Trupin KM, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol. 2010;130(10):2489-2496.
9. Yang E, Zou QP, Zhang HS. Expression and significance of DNMT1 in human keloid fibroblast [in Chinese]. [Article in Chinese]. Zhonghua Zheng Xing Wai Ke Za Zhi. 2013;29(2):117-20.
10. Zou QP, Yang E, Zhang HS. Effect of the methylation enzyme inhibitors of 5-aza-2-deoxycytidine on the TGF-beta/ smad signal transduction pathway in human keloid fibroblasts [in Chinese].Zhonghua Zheng Xing Wai Ke Za Zhi. 2013;29(4):285-289.
11. Krajewska M, Krajewski S, Epstein JI, et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol. 1996;148(5): 1567-1576.
12. van der Veer WM, Bloemen MC, Ulrich MM, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns. 2009;35(1):15-29.
13. Koonin AJ. The aetiotogy of keloids: a review of the literature and a new hypothesis. S Afr Med J. 1964;38:913-916.
14. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007;447(7143):425-432.
15. Day JJ, Sweatt JD. DNA methylation and memory formation. Nat Neurosci. 2010;13(11):1319-1323.
16. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005;15(5):490-495.
17. Bestor T, Laudano A, Mattaliano R, Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol. 1988;203(4):971-983.
18. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69(6):915-926.
19. Robert MF, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet. 2003;33(1):61-65.
20. Mizuno S, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001;97(5):1172-1179.
21. Bechtel W, McGoohan S, Zeisberg EM, et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010;16(5):544-550.
22. Marmorstein R, Roth SY. Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev. 2001;11(2):155-161.
23. Platta CS, Greenblatt DY, Kunnimalaiyaan M, Chen H. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. J Surg Res. 2007;142(2): 219-226.
24. Diao JS, Xia WS, Yi CG, et al. Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. Arch Dermatol Res. 2011;303(8):573-580.
25. Sato M. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol. 2006;86(4):300-307.
26. Tang B, Zhu B, Bi LK, Xue CL, Cai H, Zhu JY. Expression of Smads in keloid scarring [in Chinese]. Zhonghua Wai Ke Za Zhi. 2009;47(12):941-943.
27. Enright BP, Sung LY, Chang CC, Yang X, Tian XC. Methylation and acetylation characteristics of cloned bovine embryos from donor cells treated with 5-aza-2'-deoxycytidine. Biol Reprod. 2005;72(4):944-948.
28. Tsuji Y, Kato Y, Tsunoda Y. The developmental potential of mouse somatic cell nuclear-transferred oocytes treated with trichostatin A and 5-aza-2-deoxycytidine. Zygote. 2009;17(2):109-115.
29. Wang Y, Su J, Wang L, et al. The effects of 5-aza-2-deoxycytidine and trichostatin A on gene expression and DNA methylation status in cloned bovine blastocysts. Cell Reprogram. 2011;13(4):297-306.
30. Yang E, Zhang Hengshu. Effect of 5-aza-2-deoxycytidine on human keloid fibroblasts [in Chinese]. Journal of Chongqing Med University. 2013;3(38):244-247.